Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) insider Donald Bergstrom sold 18,895 shares of Relay Therapeutics stock in a transaction that occurred on Tuesday, January 27th. Relay Therapeutics Stock PerformanceRLAY traded up $0.06 during trading on Thursday, hitting $7.71. Get Relay Therapeutics alerts:Relay Therapeutics (NASDAQ:RLAY – Get Free Report) last issued its quarterly earnings data on Thursday, November 6th. Relay Therapeutics leverages computational modeling, structural biology, and experimental validation to identify small-molecule drug candidates that modulate the behavior of disease-associated proteins. See AlsoReceive News & Ratings for Relay Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relay Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.